Panacea Life Sciences Holdings, Inc. Other Cost of Operating Revenue
Panacea Life Sciences Holdings, Inc. (PLSH) reported Other Cost of Operating Revenue of $0 for the 3-month period ending 2021-03-31, per its 10-Q/A filed 2021-05-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherCostOfOperatingRevenue · last filed 2021-05-27
- Panacea Life Sciences Holdings, Inc. other cost of operating revenue for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- Panacea Life Sciences Holdings, Inc. other cost of operating revenue for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- Panacea Life Sciences Holdings, Inc. other cost of operating revenue for the quarter ending 2020-06-30 was $60.00K, a 40.25% decline year-over-year.
- Panacea Life Sciences Holdings, Inc. other cost of operating revenue for the quarter ending 2020-03-31 was $357.78K.
| Period end | Other Cost of Operating Revenue 3 month | Other Cost of Operating Revenue 3 month as first filed | Other Cost of Operating Revenue 6 month | Other Cost of Operating Revenue 9 month |
|---|---|---|---|---|
| 2021-03-31 | $0.00 10-Q/A · filed 2021-05-27 | |||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-18 | $60.00K derived: sum of 2 quarters · filed 2020-11-18 | $417.78K 10-Q · filed 2020-11-18 | |
| 2020-06-30 | $60.00K 10-Q · filed 2020-08-19 | $417.78K 10-Q · filed 2020-08-19 | ||
| 2020-03-31 | $357.78K 10-Q/A · filed 2021-05-27 | |||
| 2019-09-30 | $100.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-18 | $200.84K derived: sum of 2 quarters · filed 2020-11-18 | $216.21K 10-Q · filed 2020-11-18 | |
| 2019-06-30 | $100.42K 10-Q · filed 2020-11-18 | $103.19K 10-Q · filed 2020-08-19 | $115.79K 10-Q · filed 2020-08-19 | |
| 2019-03-31 | $0.00 10-Q · filed 2020-06-29 |